EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors

Dominik Straszak, Sylwia Woźniak iD, Agata Siwek, Monika Głuch-Lutwin, Marcin Kołaczkowski, Aldona Pietrzak iD, Bartłomiej Drop, Dariusz Matosiuk iD

Molecules · 2024

DOI: 10.3390/molecules29030571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Dominik Straszak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University, Chodzki 4A, 20-093 Lublin, Pol…. Hauptthemen laut MEDLINE: Receptors, Opioid, Receptors, Opioid, mu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin, Medical University of Lublin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

μ-opioid receptor ligands such as morphine and fentanyl are the most known and potent painkillers. However, the severe side effects seen with their use significantly limit their widespread use. The continuous broadening of knowledge about the properties of the interactions of the MOP receptor (human mu opioid receptor, OP3) with ligands and specific intracellular signaling pathways allows for the designation of new directions of research with respect to compounds with analgesic effects in a mechanism different from classical ligands. Allosteric modulation is an extremely promising line of research. Compounds with modulator properties may provide a safer alternative to the currently used opioids. The aim of our research was to obtain a series of urea derivatives of 1-aryl-2-aminoimidazoline and to determine their activity, mechanism of biological action and selectivity toward the MOP receptor. The obtained compounds were subjected to functional tests (cAMP accumulation and β-arrestin recruitment) in vitro. One of the obtained compounds, when administered alone, did not show any biological activity, while when co-administered with DAMGO, it inhibited β-arrestin recruitment. These results indicate that this compound is a negative allosteric modulator (NAM) of the human MOP receptor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, OpioidReceptors, Opioid, muHumansAnalgesics, OpioidAnalgesicsbeta-Arrestins

Stichwörter der Autor:innen

1-aryl-2-aminoimidazoline-2MOP receptorOP3 receptorallosterismβ-arrestin

Substanzen

Receptors, OpioidReceptors, Opioid, muAnalgesics, OpioidAnalgesicsbeta-Arrestins

Autor:innen und Institutionen

  • Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University, Chodzki 4A, 20-093 Lublin, Poland.
  • Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.
  • Department of Dermatology, Venereology, and Paediatric Dermatology, Faculty of Medicine, Medical University, Staszica 11, 20-080 Lublin, Poland.
  • Department of Medical Informatics and Statistics, Medical University, Jaczewskiego 4, 20-090 Lublin, Poland.

ORCID-Profile: Sylwia Woźniak, Aldona Pietrzak, Dariusz Matosiuk

Förderung

  • Medical University of Lublin
  • Medical University of Lublin, Poland

Zitieren

APA

Straszak, D., Woźniak, S., Siwek, A., Głuch-Lutwin, M., Kołaczkowski, M., Pietrzak, A., Drop, B., & Matosiuk, D. (2024). Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors. Molecules. https://doi.org/10.3390/molecules29030571

Vancouver

Straszak D, Woźniak S, Siwek A, Głuch-Lutwin M, Kołaczkowski M, Pietrzak A, et al. Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors. Molecules. 2024. doi:10.3390/molecules29030571

BibTeX
@article{Straszak2024,
  author = {Straszak, Dominik and Woźniak, Sylwia and Siwek, Agata and Głuch-Lutwin, Monika and Kołaczkowski, Marcin and Pietrzak, Aldona and Drop, Bartłomiej and Matosiuk, Dariusz},
  title = {Novel 1-(1-Arylimiazolin-2-Yl)-3-Arylalkilurea Derivatives with Modulatory Activity on Opioid MOP Receptors},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29030571}
}
Kostenlos starten →